Solborn

Solborn ROE

The Return on Equity (ROE) of Solborn (035610.KQ) as of Oct 20, 2026 is 9.82 %. In the previous year, Return on Equity (ROE) was 17.88 % — a change of -45.10% (lower).

ROE

9.82 %

YoY

-45.10%

Last updated:

In 2025, Solborn's return on equity (ROE) was 9.82 %, a -45.10% increase from the 17.88 % ROE in the previous year.

The Solborn ROE history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

ROE
Date
ROE
Jan 1, 2018
7.16 KRW
Jan 1, 2019
1.27 KRW
Jan 1, 2020
1.04 KRW
Jan 1, 2021
11.03 KRW
Jan 1, 2022
-33.68 KRW
Jan 1, 2023
23.22 KRW
Jan 1, 2024
17.88 KRW
Jan 1, 2025
9.82 KRW
The Solborn ROE history
YEARROEYoY
9.82 %-45.10%
17.88 %-23.00%
23.22 %-168.93%
-33.68 %-405.41%
11.03 %+956.68%
1.04 %-17.69%
1.27 %-82.29%
7.16 %-261.78%
-4.43 %-1,572.69%
0.30 %-73.98%
1.15 %-72.94%
4.27 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Solborn Stock analysis

What does Solborn do? Solborn Inc, identified by the ticker symbol 035610.KQ and ISIN KR7035610005, is a South Korean enterprise operating within the Health Care sector. Headquartered in Seoul, the company went public on August 13, 1999, and maintains a digital presence at http://www.solborn.co.kr/. Despite its classification in the health care industry, Solborn functions primarily as a holding company that engages in the participation and management advisory of other firms through shareholding. The organization currently employs nine full-time staff members who oversee its diverse portfolio of subsidiaries and assets. A significant portion of its holding business involves the investment and management of its subsidiary companies, most notably INFINITT Healthcare Co., Ltd. This subsidiary is engaged in the manufacture of medical image processing systems, which include picture archiving and communication systems, commonly known as PACS. These systems are critical tools in modern healthcare facilities for storing, retrieving, and displaying medical images. In addition to its health care interests, Solborn holds stakes in Focus Newspaper Co., Ltd., a company involved in newspaper publishing, advertising, and printing businesses. The group also includes Solborn Investment Co., Ltd., which focuses on venture investment activities, thereby diversifying the parent company's financial exposure across different economic sectors. Beyond its equity investments, Solborn operates a rental business segment. This division involves the leasing of real estate assets, specifically including CHEONG DAM SPOPIA, which is described as a golf park. The company also leases industrial real estates, adding a tangible asset component to its revenue streams. The combination of healthcare technology manufacturing, media publishing, venture capital, and real estate leasing illustrates a multifaceted corporate structure. While the parent company itself does not directly manufacture medical devices or publish newspapers, its strategic shareholdings allow it to influence and benefit from the operations of these specialized subsidiaries. The company's long-standing presence in the market, evidenced by its 1999 IPO, suggests an established history of navigating the South Korean business landscape. Its small workforce indicates a lean operational model, likely relying on the management structures of its subsidiaries to execute day-to-day business activities while the parent company focuses on high-level strategic oversight and financial management. Solborn is one of the most popular companies on Eulerpool.

ROE Details

Decoding Solborn's Return on Equity (ROE)

Solborn's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing Solborn's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

Solborn's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in Solborn’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about Solborn stock

Return on Equity (ROE) of Solborn is 9.82 % in 2025.

Return on Equity (ROE) of Solborn changed from 17.88 % to 9.82 %, representing a -45.10% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Return on Equity (ROE) Solborn since 2006 – with annual values, charts, and detailed analysis.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Equity (ROE)'s Solborn with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Equity (ROE)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Equity (ROE).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Solborn

All Key Metrics — Solborn